BRECISE accelerates the transition of biomarkers from the laboratory into everyday clinical practice. The project develops tools for more precise treatment of prostate and bladder cancer, connects data, artificial intelligence and regulation, and creates a framework that can support patients, clinicians and healthcare systems across Europe in advancing personalised medicine and care.